<DOC>
	<DOCNO>NCT00320502</DOCNO>
	<brief_summary>The purpose study determine safety feasibility BXT-51072 cardioprotective agent diabetic undergo elective angioplasty / percutaneous intervention ( PCI ) , procedure `` open '' coronary artery . BXT-51072 belongs class drug call `` glutathione peroxidase mimic . '' BXT-51072 work imitate substance produce various tissue body , prevents damage heart blood vessel .</brief_summary>
	<brief_title>A Phase 2 Study Determine Effects BXT-51072 Diabetic Patients Undergoing Angioplasty ( PCI )</brief_title>
	<detailed_description>Following screening , baseline measurement inform consent , patient receive BXT-51072 40 mg placebo 2:1 ratio , 30 minute schedule PCI three time per day 2 day . There 5 treatment visit 3 follow-up visit . Blood sample obtain CK-MB , troponin routine chemistry . A 24-hour continuous electrocardiogram obtain follow PCI regular electrocardiogram obtain study follow-up period .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Type 2 diabetes Scheduled elective angioplasty acute coronary syndrome within 72 hour MI within 7 day CKMB normal Elevated troponin show decrease value Congestive heart failure Atrial fibrillation leave bundle branch block Uncontrolled diabetes</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>